Trial · NCT04116112
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Femoral artery Pseudoaneurysm | Vascular disorders | Higher Systolic Blood Pressure (SBP) Target | 1 | 40 | |
| serious | Femoral artery Pseudoaneurysm | Vascular disorders | Lower SBP (<160 mmHg) Target | 0 | 40 | |
| serious | Femoral artery Pseudoaneurysm | Vascular disorders | Lower SBP (<140mmHg) Target | 0 | 40 | |
| serious | Sepsis and cardiac failure | Infections and infestations | Higher Systolic Blood Pressure (SBP) Target | 0 | 40 | |
| serious | Sepsis and cardiac failure | Infections and infestations | Lower SBP (<160 mmHg) Target | 1 | 40 | |
| serious | Sepsis and cardiac failure | Infections and infestations | Lower SBP (<140mmHg) Target | 0 | 40 | |
| serious | Aspiration Pneumonia | Infections and infestations | Higher Systolic Blood Pressure (SBP) Target | 0 | 40 | |
| serious | Aspiration Pneumonia | Infections and infestations | Lower SBP (<160 mmHg) Target | 2 | 40 | |
| serious | Aspiration Pneumonia | Infections and infestations | Lower SBP (<140mmHg) Target | 0 | 40 | |
| serious | Carotid artery re-occlusion | Vascular disorders | Higher Systolic Blood Pressure (SBP) Target | 0 | 40 | |
| serious | Carotid artery re-occlusion | Vascular disorders | Lower SBP (<160 mmHg) Target | 0 | 40 | |
| serious | Carotid artery re-occlusion | Vascular disorders | Lower SBP (<140mmHg) Target | 1 | 40 | |
| serious | Subarachnoid hemorrhage | Nervous system disorders | Higher Systolic Blood Pressure (SBP) Target | 0 | 40 | |
| serious | Subarachnoid hemorrhage | Nervous system disorders | Lower SBP (<160 mmHg) Target | 0 | 40 | |
| serious | Subarachnoid hemorrhage | Nervous system disorders | Lower SBP (<140mmHg) Target | 1 | 40 | |
| serious | Gastrointestinal hemorrhage associated with gastric ulcer | Gastrointestinal disorders | Higher Systolic Blood Pressure (SBP) Target | 0 | 40 | |
| serious | Gastrointestinal hemorrhage associated with gastric ulcer | Gastrointestinal disorders | Lower SBP (<160 mmHg) Target | 0 | 40 | |
| serious | Gastrointestinal hemorrhage associated with gastric ulcer | Gastrointestinal disorders | Lower SBP (<140mmHg) Target | 1 | 40 | |
| serious | New contralateral large vessel occlusion stroke | Nervous system disorders | Higher Systolic Blood Pressure (SBP) Target | 0 | 40 | |
| serious | New contralateral large vessel occlusion stroke | Nervous system disorders | Lower SBP (<160 mmHg) Target | 0 | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04116112/events